For: | Grotz TE, Royal RE, Mansfield PF, Overman MJ, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF. Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade. World J Gastrointest Oncol 2017; 9(9): 354-362 [PMID: 28979717 DOI: 10.4251/wjgo.v9.i9.354] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v9/i9/354.htm |
Number | Citing Articles |
1 |
Mikael L. Soucisse, Joshua Lansom, Mohammad S. Alshahrani, David L. Morris. Mucinous appendiceal neoplasms with or without pseudomyxoma peritonei: a review. ANZ Journal of Surgery 2020; 90(10): 1888 doi: 10.1111/ans.16185
|
2 |
Laura M. Legué, Geert-Jan Creemers, Ignace H.J.T. de Hingh, Valery E.P.P. Lemmens, Clément J. Huysentruyt. Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei. Clinical Colorectal Cancer 2019; 18(1): 1 doi: 10.1016/j.clcc.2018.11.007
|
3 |
Adam C. Fields, Pamela W. Lu, George Z. Li, Vanessa Welten, Joshua S. Jolissaint, Benjamin M. Vierra, Lily V Saadat, Abby C. Larson, Rachel B. Atkinson, Nelya Melnitchouk. Current practices and future steps for hyperthermic intraperitoneal chemotherapy. Current Problems in Surgery 2020; 57(3): 100727 doi: 10.1016/j.cpsurg.2019.100727
|
4 |
Vasileios Tsagkalidis, Jennie K. Choe, Toni Beninato, Mariam F. Eskander, Miral S. Grandhi, Haejin In, Timothy J. Kennedy, Russell C. Langan, Jason C. Maggi, Henry A. Pitt, H. Richard Alexander, Brett L. Ecker. Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies. Annals of Surgical Oncology 2024; 31(7): 4203 doi: 10.1245/s10434-024-15233-9
|
5 |
Yosef Y. Nasseri, Ruoyan Zhu, Christine Sutanto, Christina Wai, Jason S. Cohen, Joshua Ellenhorn, Avo Artinyan. Role of right hemicolectomy in patients with low-grade appendiceal mucinous adenocarcinoma. The American Journal of Surgery 2019; 218(6): 1239 doi: 10.1016/j.amjsurg.2019.07.035
|
6 |
Muhammad Talha Waheed, Ibrahim Malik, Andrew M. Blakely, Yasmine Zerhouni, Mark Hanna, Kurt Melstrom, Lily L. Lai, Andreas M. Kaiser, Lwin Thinzar, Isaac B. Paz, Mustafa Raoof. Who should get a right colectomy in low-grade appendiceal adenocarcinomas? Association of lymphovascular invasion and nodal metastases. Surgery 2024; 176(3): 560 doi: 10.1016/j.surg.2024.05.040
|
7 |
Nick C. Levinsky, Mackenzie C. Morris, Koffi Wima, Jeffrey J. Sussman, Syed A. Ahmad, Jordan M. Cloyd, Charles Kimbrough, Keith Fournier, Andrew Lee, Sean Dineen, Sophie Dessureault, Jula Veerapong, Joel M. Baumgartner, Callisia Clarke, Mohammad Y. Zaidi, Charles A. Staley, Shishir K. Maithel, Jennifer Leiting, Travis Grotz, Laura Lambert, Ryan J. Hendrix, Sean Ronnekleiv-Kelly, Courtney Pokrzywa, Mustafa Raoof, Oliver S. Eng, Fabian M. Johnston, Jonathan Greer, Sameer H. Patel. Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative. Journal of Gastrointestinal Surgery 2020; 24(1): 155 doi: 10.1007/s11605-019-04336-4
|
8 |
Erika Belmont, Varun V. Bansal, Mahmoud M.G. Yousef, Mohammad A. Zeineddine, David Su, Ankit Dhiman, Chih-Yi Liao, Blasé Polite, Oliver S. Eng, Keith F. Fournier, Michael G. White, Kiran K. Turaga, John Paul Shen, Ardaman Shergill. Multi-Institutional Study Evaluating the Role of Circulating Tumor DNA in the Management of Appendiceal Cancers. JCO Precision Oncology 2024; (8) doi: 10.1200/PO.23.00531
|
9 |
Yu-Lin Lin, Da-Zhao Xu, Xin-Bao Li, Feng-Cai Yan, Hong-Bin Xu, Zheng Peng, Yan Li. Consensuses and controversies on pseudomyxoma peritonei: a review of the published consensus statements and guidelines. Orphanet Journal of Rare Diseases 2021; 16(1) doi: 10.1186/s13023-021-01723-6
|
10 |
Juan P. Cata, Linh T. Nguyen, Ifeyinwa C. Ifeanyi-Pillette, Antoinette Van Meter, Lori A. Dangler, Lei Feng, Pascal Owusu-Agyemang. An assessment of the survival impact of multimodal anesthesia/analgesia technique in adults undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a propensity score matched analysis. International Journal of Hyperthermia 2019; 36(1): 368 doi: 10.1080/02656736.2019.1574985
|
11 |
Samer S. AlMasri, Abdulrahman Y. Hammad, Aatur D. Singhi, Alessandro Paniccia, Amer H. Zureikat, James P. Celebrezze, Haroon A. Choudry, Ibrahim Nassour. Appendectomy Is Oncologically Equivalent to Right Hemicolectomy for Well-Differentiated T1 Appendiceal Adenocarcinoma. Diseases of the Colon & Rectum 2023; 66(1): 67 doi: 10.1097/DCR.0000000000002089
|
12 |
L Martín-Román, P Lozano, W Vásquez, N Palencia, Y Gómez, M J Fernández-Aceñero, L González-Bayón. Defining stage in mucinous tumours of the appendix with peritoneal dissemination: the importance of grading terminology: systematic review. BJS Open 2021; 5(4) doi: 10.1093/bjsopen/zrab059
|
13 |
Xin Zhao, Xinbao Li, Yulin Lin, Ru Ma, Ying Zhang, Dazhao Xu, Yan Li. Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Cancer Medicine 2023; 12(3): 2637 doi: 10.1002/cam4.5138
|
14 |
Puja Sakhuja, K. P. Aravindan. Surgical Pathology of the Gastrointestinal System. 2022; : 895 doi: 10.1007/978-981-16-6395-6_21
|
15 |
Melissa W. Taggart, Wai Chin Foo, Sun Mi Lee. Oncological Surgical Pathology. 2020; : 691 doi: 10.1007/978-3-319-96681-6_12
|
16 |
Michael G. White, Mohammad A. Zeineddine, Eleanor A. Fallon, Fadl A. Zeineddine, Julia Dansby, Saikat Chowdhury, Nicholas Hornstein, Abdelrahman Yousef, Mahmoud Yousef, Neal Bhutiani, Yue Gu, Bryan Kee, Arvind Dasari, Michael J. Overman, Kanwal Raghav, Scott Kopetz, Abhineet Uppal, Melissa Taggart, Timothy Newhook, Keith Fournier, Beth Helmink, Leylah M. Drusbosky, John Paul Shen. The Landscape of ctDNA in Appendiceal Adenocarcinoma. Clinical Cancer Research 2025; 31(3): 551 doi: 10.1158/1078-0432.CCR-24-2474
|
17 |
Jiahua Zhou, Yeye Yi, Congjun Wang, Cheng Su, Yige Luo. Identification of a 3‑mRNA signature as a novel potential prognostic biomarker in patients with ovarian serous cystadenocarcinoma in G2 and G3. Oncology Letters 2019; doi: 10.3892/ol.2019.10701
|
18 |
Pamela Lu, Adam C. Fields, Jeffrey A. Meyerhardt, Jennifer S. Davids, Galyna Shabat, Ronald Bleday, Joel E. Goldberg, Garrett M. Nash, Nelya Melnitchouk. Systemic chemotherapy and survival in patients with metastatic low‐grade appendiceal mucinous adenocarcinoma. Journal of Surgical Oncology 2019; 120(3): 446 doi: 10.1002/jso.25599
|
19 |
Paul H. McClelland, Stephanie N. Gregory, Shirley K. Nah, Jonathan M. Hernandez, Jeremy L. Davis, Andrew M. Blakely. Predicting Survival in Mucinous Adenocarcinoma of the Appendix: Demographics, Disease Presentation, and Treatment Methodology. Annals of Surgical Oncology 2024; 31(9): 6237 doi: 10.1245/s10434-024-15526-z
|
20 |
John Paul Shen, Abdelrahman M. Yousef, Fadl A. Zeineddine, Mohammad A. Zeineddine, Rebecca S. Tidwell, Karen A. Beaty, Lisa C. Scofield, Safia Rafeeq, Nicholas Hornstein, Elizabeth Lano, Cathy Eng, Aurelio Matamoros, Wai Chin Foo, Abhineet Uppal, Christopher Scally, Paul Mansfield, Melissa Taggart, Kanwal P. Raghav, Michael J. Overman, Keith Fournier. Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma. JAMA Network Open 2023; 6(6): e2316161 doi: 10.1001/jamanetworkopen.2023.16161
|
21 |
Sarah E. Umetsu, Sanjay Kakar. Staging of appendiceal mucinous neoplasms: challenges and recent updates. Human Pathology 2023; 132: 65 doi: 10.1016/j.humpath.2022.07.004
|
22 |
Celina S.-P. Ang, John Paul Shen, Camille J. Hardy-Abeloos, Justin K. Huang, Jeffrey S. Ross, Vincent A. Miller, Miriam T. Jacobs, Ingrid L. Chen, David Xu, Siraj M. Ali, Joel Baumgartner, Andrew Lowy, Paul Fanta, Trey Ideker, Sherri Z. Millis, Olivier Harismendy. Genomic Landscape of Appendiceal Neoplasms. JCO Precision Oncology 2018; (2): 1 doi: 10.1200/PO.17.00302
|
23 |
Robert F. Bradley, Norman J. Carr. Pseudomyxoma Peritonei: Pathology, a Historical Overview, and Proposal for Unified Nomenclature and Updated Grading. AJSP: Reviews and Reports 2019; 24(3): 88 doi: 10.1097/PCR.0000000000000305
|
24 |
Nuha Shaker, Jon Davison, Joshua Derby, Ibrahim Abukhiran, Akila Mansour, Matthew Holtzman, Haroon Choudry, Reetesh K. Pai. TP53 Alterations Are an Independent Adverse Prognostic Indicator in Pseudomyxoma Peritonei of Appendiceal Origin Following Cytoreductive Surgery and Intraperitoneal Chemotherapy. Applied Immunohistochemistry & Molecular Morphology 2025; doi: 10.1097/PAI.0000000000001245
|
25 |
Abdelrahman Yousef, Mahmoud Yousef, Mohammad A. Zeineddine, Aditya More, Mohammad Fanaeian, Saikat Chowdhury, Mark Knafl, Paul Edelkamp, Ichiaki Ito, Yue Gu, Vinay Pattalachinti, Zahra Alavi Naini, Fadl A. Zeineddine, Jennifer Peterson, Kristin Alfaro, Wai Chin Foo, Jeff Jin, Neal Bhutiani, Victoria Higbie, Christopher P. Scally, Bryan Kee, Scott Kopetz, Drew Goldstein, Madeleine Strach, Andrew Williamson, Omer Aziz, Jorge Barriuso, Abhineet Uppal, Michael G. White, Beth Helmink, Keith F. Fournier, Kanwal P. Raghav, Melissa W. Taggart, Michael J. Overman, John Paul Shen. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma. JAMA Network Open 2024; 7(2): e240260 doi: 10.1001/jamanetworkopen.2024.0260
|